TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer October 20, 1995
TCL Archive In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director May 22, 1998
TCL Archive DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio January 1, 1988
TCL Archive Breast Cancer Action Plan Committee Outrages By Plans for $14M In NCI Funds August 1, 1997
